Newer biologic agents are now used, either off-label or after approval by regulatory agencies in the U.S., Europe, and other countries. Other potential drug products are being investigated as new ...

AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years. The European Commission has ...

You were either on cyclophosphamide, or you weren’t on anything, leaving people subject to lupus flares. Then, in 2002, a study out of Europe called the Euro-Lupus Nephritis Trial found that lower ...

Gazyva has also been filed for the lupus nephritis indication in Europe, said Roche, which is also expecting a readout from the phase 3 ALLEGORY trial in a broader SLE population later in 2025 and ...

Cutaneous lupus affects quality of life by limiting social participation and increasing mental health concerns, according to ...

Long term, steroids can damage the patient more than the lupus.” Mosca was part of an international team that updated European guidelines, issued by European Alliance of Associations for ...